VANCOUVER, BC / ACCESSWIRE / July 7, 2023 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6 ), (WKN: A3CSSU) (the " Company " or " Core One ") is pleased to announce that its wholly owned subsidiary, Vocan Biotechnologies Inc. (" Vocan "), has completed final steps of its research for its biosynthetic production system (the System) and has filed a patent under the Patent Cooperation Treaty (PCT) (the "... Read More

VANCOUVER, BC / ACCESSWIRE / May 1, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 )(WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce that its wholly-owned subsidiaries, GMP Drug Inc., and Awakened Biosciences Inc. (" Awakened ") will commence the development and manufacturing of psychedelic prodrugs through its partnership with a compounding pharmacy (the " Pharmacy ") based in... Read More

VANCOUVER, BC / ACCESSWIRE / January 13, 2023 / Core One Labs Inc. (CSE: COOL ) (OTCQB: CLABF ) (Frankfurt: LD6 ) (WKN: A3CSSU) (the " Company " or " Core One "), is pleased to announce that it has acquired (the " Acquisition ") GMP Drug Inc. (" GMP Drug "), an arms-length privately held company that operates through a Good Manufacturing Practices (" GMP ") facility (the " Facility ") owned by a third-party located in... Read More

VANCOUVER, BC / ACCESSWIRE / November 18, 2022 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6 , WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce the initial production run of its psilocybin active pharmaceutical ingredient (API) product at a good manufacturing practices (GMP) facility is projected for January 2023, to test the Company's commercial production capabilities. After a... Read More